Brief: ALX Oncology Q1 Basic EPS USD -0.71
09/05/2024 21:00
May 09 (Reuters) - ALX Oncology Q1 net income USD -35.581 million. * Q1 income from operations USD -37.762 million vs. IBES estimate USD -42.5 million * Q1 operating expenses USD 37.762 million
Recent news on ALX Oncology Holdings
See all newsALX Oncology Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
ALX Oncology Holdings Inc expected to post a loss of 15 cents a share - Earnings Preview
ALX Oncology Q2 net loss narrows on lower R&D costs
Brief: ALX Oncology Q2 Basic EPS USD -0.13
Brief: Alx Oncology Holdings - Enters Loan And Security Agreement With HSBC Ventures On June 25, 2026 - SEC Filing